Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
05/2013
05/09/2013US20130115163 Synthesis of mse-framework type molecular sieves
05/08/2013CN103097381A 1, 8-naphthyridines as kinase inhibitors
05/08/2013CN103087058A Method for recovery catalyst quinine used in meso cyclic anhydride desymmetrisation reaction
05/08/2013CN103087057A Waste quinine recovery method
05/07/2013US8436181 Production process of optically active 3-quinuclidinol derivative
05/02/2013WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative
05/02/2013CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative
05/01/2013EP2585459A1 Alkaloid aminoester derivatives and medicinal compositions thereof
05/01/2013EP2585458A1 Alkaloid aminoester derivatives and medicinal composition thereof
05/01/2013EP2585457A1 Alkaloid aminoester derivatives and medicinal composition thereof
04/2013
04/25/2013US20130102592 Oxazole tyrosine kinase inhibitors
04/24/2013CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
04/24/2013CN101735213B Optical isomer of penehyclidine and medicinal composition and application thereof
04/23/2013CA2565632C Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
04/23/2013CA2529257C Methods and compositions for treating amyloid-related diseases
04/18/2013US20130095193 Compounds useful as inhibitors of atr kinase
04/17/2013CN102120740B Imidazoline compound chirally synthesized by using thiourea catalyst derived from rosin and application thereof in anti-inflammatory and antipyretic aspects
04/10/2013CN101684118B Use of tricyclic compounds as glycine transport inhibitors
04/10/2013CN101605784B Aza-bridged-ring compound
04/03/2013CN103012396A Transfer method for isomers of palonosetron hydrochloride
04/03/2013CN101597286B Organic catalyst containing primary amine, tertiary amine and urea or thiourea and preparation method thereof
03/2013
03/28/2013WO2013043961A1 Compounds useful as inhibitors of choline kinase
03/28/2013WO2013043960A1 Compounds useful as inhibitors of choline kinase
03/28/2013WO2013041655A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
03/28/2013US20130079521 Novel palonosetron salts and processes for preparation and purification thereof
03/28/2013US20130079351 2-acylaminothiazole derivative or salt thereof
03/28/2013CA2849442A1 Compounds useful as inhibitors of choline kinase
03/28/2013CA2847186A1 Compounds useful as inhibitors of choline kinase
03/28/2013CA2845720A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
03/27/2013EP2573079A2 Benzimidazole quinolinones and uses thereof
03/27/2013EP2571874A1 A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
03/21/2013US20130072517 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
03/20/2013EP2570128A1 Muscarinic acetylcholine receptor antagonists
03/14/2013US20130066069 Processes for preparing substituted pyrimidines
03/07/2013US20130060039 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
03/06/2013CN101851233B Palonosetron hydrochloride, and precursor compound thereof
02/2013
02/28/2013WO2013028999A1 Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
02/27/2013EP2562253A1 Modified carbonyl reductase, gene thereof, and method of producing optically active alcohols using these
02/27/2013CN102947300A Alkaloid aminoester derivatives and medicinal compositions thereof
02/27/2013CN102947299A Alkaloid aminoester derivatives and medicinal composition thereof
02/27/2013CN102947298A Alkaloid aminoester derivatives and medicinal composition thereof
02/27/2013CN101824033B Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
02/21/2013WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors
02/21/2013US20130045169 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
02/14/2013US20130040987 Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
02/13/2013CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy
02/12/2013CA2570155C 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases
02/12/2013CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors
02/06/2013CN102212064B Method for preparing quinindium and cinchonine
02/05/2013CA2520894C Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
01/2013
01/31/2013US20130030184 Isotopically labeled chemically stable reagents and process for the synthesis thereof
01/31/2013US20130030015 Muscarinic acetylcholine receptor antagonists
01/31/2013US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
01/31/2013US20130030001 Quinuclidine derivatives as muscarinic m3 receptor antagonists
01/29/2013US8362008 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors
01/29/2013CA2544492C Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
01/24/2013WO2013012827A1 Diaminocyclohexane compounds and uses thereof
01/24/2013WO2013010916A1 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
01/24/2013WO2013010679A1 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
01/24/2013CA2841546A1 Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
01/23/2013CN102887894A Crystal form of solifenacin succinate and preparation method thereof
01/22/2013CA2583237C Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
01/22/2013CA2515777C Biphenyl derivatives
01/17/2013US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
01/16/2013CN102875544A Preparation technology of solifenacin succinate
01/15/2013US8354536 Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides
01/10/2013WO2013004290A1 Cyclic amine derivatives as ep4 receptor antagonists
01/10/2013CA2839116A1 Cyclic amine derivatives as ep4 receptor antagonists
01/09/2013CN102863374A Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
01/09/2013CN101925600B Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester
01/03/2013US20130005730 Novel 1,3-oxazolidine compounds and their use as renin inhibitors
01/03/2013US20130005695 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
01/02/2013EP2539336A2 Hetarylaminonaphthyridines
01/02/2013EP2539335A1 Process for the preparation of isoxazoline derivatives
01/02/2013EP2182949B1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
01/02/2013CN102850345A Quaternary ammonium salt and its pharmaceutical composition and its use
01/02/2013CN102850344A Medicinal application of penehyclidine optical isomer derivative in anti-tumor
12/2012
12/27/2012WO2012175119A1 Process for the preparation of solifenacin and salts thereof
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/25/2012US8338429 2-acylaminothiazole derivative or salt thereof
12/18/2012US8334388 Palonosetron salts and processes for preparation and purification thereof
12/18/2012US8334303 Specifically mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate (SB 268091); use as antibiotic; crystallization from isopropanol; improved bioavailability, and/or physical properties, for example solubility or flow properties
12/13/2012WO2012168359A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/13/2012US20120316341 Fluorination of organic compounds
12/12/2012CN102822168A Process for the preparation of isoxazoline derivatives
12/11/2012US8329934 Isotopically labeled chemically stable reagents and process for the synthesis thereof
12/11/2012US8329771 Photobase generator
11/2012
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/28/2012CN101641350B Dibenzo[b, f][1, 4]oxazapine compounds
11/27/2012CA2695742C Bicyclic amides for enhancing glutamatergic synaptic responses
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/15/2012US20120288501 Substituted benzazoles and methods of their use as inhibitors of raf kinase
11/14/2012CN102781939A Palonosetron metabolites
11/13/2012US8309572 Muscarinic acetylcholine receptor antagonists
11/13/2012CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
11/07/2012CN102766140A Process for separating and preparing quinine sulfate from peruvian bark
11/06/2012US8304545 Quinuclidine derivative useful in the preparation of mequitazine
11/06/2012US8304544 Palonosetron free base and process for its preparation
11/06/2012CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/01/2012WO2012146515A1 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 58